Voyageur Pharmaceuticals Stock Today
| VM Stock | CAD 0.07 0.02 44.44% |
Performance1 of 100
| Odds Of DistressOver 64
|
Voyageur Pharmaceuticals is selling for under 0.065 as of the 17th of April 2024; that is 44.44 percent increase since the beginning of the trading day. The stock's lowest day price was 0.065. Voyageur Pharmaceuticals has more than 64 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Voyageur Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of April 2022 and ending today, the 17th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Voyageur Minerals Ltd., an exploration stage company, engages in acquiring, exploring, and developing mineral exploration properties. The company also has interests in the Paradox Basin and Lithium King lithium brine projects in Utah. VOYAGEUR MINERALS operates under Industrial Metals Minerals classification in Canada and is traded on TSX Venture Exchange.. The company has 138.81 M outstanding shares of which 9.54 K shares are at this time shorted by private and institutional investors with about 0.07 trading days to cover. More on Voyageur Pharmaceuticals
Moving against Voyageur Stock
| 0.67 | FFH-PK | Fairfax Financial | PairCorr |
| 0.65 | ELF | E L Financial | PairCorr |
| 0.65 | FFH-PI | Fairfax Financial | PairCorr |
| 0.63 | FFH-PH | Fairfax Financial | PairCorr |
| 0.63 | FFH-PC | Fairfax Fin Hld | PairCorr |
| 0.61 | FFH-PE | Fairfax Financial | PairCorr |
| 0.6 | FFH | Fairfax Financial | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Voyageur Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Voyageur Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Voyageur Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Brent Willis | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Industrial Metals & Minerals, Basic Materials (View all Sectors) | ||||
Voyageur Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Voyageur Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Voyageur Pharmaceuticals' financial leverage. It provides some insight into what part of Voyageur Pharmaceuticals' total assets is financed by creditors.
| |||||
Voyageur Pharmaceuticals (VM) is traded on TSX Venture Exchange in Canada and employs 12 people. Voyageur Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Voyageur Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Voyageur Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Voyageur Pharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 138.81 M outstanding shares of which 9.54 K shares are at this time shorted by private and institutional investors with about 0.07 trading days to cover.
Voyageur Pharmaceuticals currently holds about 27.59 K in cash with (991.25 K) of positive cash flow from operations.
Check Voyageur Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationVoyageur Pharmaceuticals maintains a total of 138.81 Million outstanding shares. Voyageur Pharmaceuticals has 10.21 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Voyageur Ownership Details
Voyageur Stock Price Odds Analysis
Depending on a normal probability distribution, the odds of Voyageur Pharmaceuticals jumping above the current price in 90 days from now is about 89.94%. The Voyageur Pharmaceuticals probability density function shows the probability of Voyageur Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Voyageur Pharmaceuticals has a beta of 0.9564. This entails Voyageur Pharmaceuticals market returns are correlated to returns on the market. As the market goes up or down, Voyageur Pharmaceuticals is expected to follow. Additionally, voyageur Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Voyageur Pharmaceuticals to move above the current price in 90 days from now is about 89.94 (This Voyageur Pharmaceuticals probability density function shows the probability of Voyageur Stock to fall within a particular range of prices over 90 days) .
Voyageur Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Voyageur Pharmaceuticals market risk premium is the additional return an investor will receive from holding Voyageur Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Voyageur Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Voyageur Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Voyageur Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.99 | |||
| Semi Deviation | 4.76 | |||
| Standard Deviation | 5.8 | |||
| Variance | 33.69 |
Voyageur Stock Against Markets
Picking the right benchmark for Voyageur Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Voyageur Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Voyageur Pharmaceuticals is critical whether you are bullish or bearish towards Voyageur Pharmaceuticals at a given time. Please also check how Voyageur Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Voyageur Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Voyageur Pharmaceuticals Corporate Directors
Voyageur Pharmaceuticals corporate directors refer to members of a Voyageur Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Voyageur Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Voyageur Pharmaceuticals' board members must vote for the resolution. The Voyageur Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Evatt Merchant | Independent Director | Profile | |
| Joseph Campo | Independent Director | Profile | |
| Greg Lindsey | Chief Financial Officer, Corporate Secretary, Director | Profile | |
| Pierre Magnan | Independent Director | Profile |
How to buy Voyageur Stock?
Before investing in Voyageur Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Voyageur Pharmaceuticals. To buy Voyageur Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Voyageur Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Voyageur Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Voyageur Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Voyageur Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Voyageur Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Voyageur Pharmaceuticals?
The danger of trading Voyageur Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Voyageur Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Voyageur Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Voyageur Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Voyageur Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Voyageur Stock analysis
When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |